...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Welcome back 'ltdcoverage'.
I enjoy reading your keen insights.
Yes, the distinction I meant was - this test is much more "accurate and reliable" in PREDICTING prostate cancer than the current "test".
Yes, a paradigm shift will make the industry gravitate towards the HDVY test.
Stocks generally do not go straight up.
They hit ceilings and retrace.
This stock blew through multi year highs - so it is natural to expect retracement. It has retraced and has based well.
So, I expect this stock to start its run again and test that ceiling.
That is the likely expectation - but will it respond? I don't know. But the odds are in our favor.
Hi Black00SS
There is no one specific purchase price - it depends on how long you want to hold this stock.
If you plan to hold this for at least a year, ask yourself does it matter if you bought it for .20 or .25 or .30 --- when you know that the potential of this stock is in the multiple $ dollar range.
Just buy it on the dips. At this time, the stock has based itself in the .20s. Just accumulate at various price points.
It can go either way from here - but these are expected oscillations of the stock.
Once this stock breaks out of its range .20-.50 there is no upper limit!
The "news" is expected soon from Abbott & Quest. NO ONE knows when. The company's PR says it is progressing well.
"that a new, more accurate test is desperately needed" --- this company's test is just what the doctor ordered!
Accuracy and reliability is the key driving point of this test.
Good point TechStockBob.
Smart money wants to stay long - because they know the true potential.
Cheers!
Yes ... this is just the beginning. This little company has so many things going for it.
Nothing like having regular cash flow -- streaming in.
True, ACS will not endorse this company - but it is the change in paradigm - the ability to precisely target and bring in credibility to the PSA test - that is what ACS will go after.
I will continue to accumulate.
Cheers.
All in good time ...
Long timers here have been holding for quite a while.
Company employees hold nearly 43%!
Dr. Barnhill is making all the right moves.
The holidays are a good time for these events to converge.
All these steps should begin to pay off shortly when Abbott & Quest start announcing. The PSA market alone is huge! You bet Abbott & Quest are salivating at how much they can make!
Like I said earlier, this one's a keeper - a great (retirement)/IRA stock.
Trust Dr. Stephen Barnhill to come out swinging!
Wow - some PR - precision targeted like his biomarker patents!
Watch out - once Abbott and/or Quest come out with their findings - full speed ahead! Watch him go after ACS and change their tune regarding PSA test's accuracy.
Again, continue to accumulate on dips. Think about it - what IF the stock jumps to $2 --- does it matter if you bought it at .20 or .25 or .30. Go figure!
Thank you Dr. Barnhill !
Long and holding.
heh heh TechStockBob - just move the decimal point by 2 places and this gem is on par!
Perhaps in 2 years this may happen!
Cheers.
Nice "bump" from the 50 EMA.
I bought some more this morning.
Hi "aliasnotinuse" - please don't get me wrong. I am not averaging down! I have lots of shares at much lower levels.
As and when I get funds from other plays, I move into those that have higher potential.
This one has a bright future (imho).
I am "averaging up" .... and holding onto it - and will not let these MMs shake me!
Continuing to accumulate dips.
Maybe the "bounce" effect of PWRM which has similar, but not as pivotal a play in personalized medicine?
Great research renmanaz!
HDVY held up well on the .20-.22 cent support and got a good bounce.
Now, let's start climbing above .30 again and test that .43 ceiling!
Plan on continuing to accumulate dips ...
Question to the board - Can HDVY be taken over by one of the giant pharma companies? I do hope not.
Or is anyone aware of any "poison pill" to help prevent being swallowed by these giant companies. I would surmise that Dr. Barnhill would not want to be taken over so soon in their young company's life - and would have taken the right steps to address that issue, given that they have done so many right moves to help towards commercializing these tests.
Cheers.
Good research shana ... this has not hit the public news feed yet.
Nice climb in the chart. Let's see if this can be sustained.
12m float and a useful product.
Cheers
If the market co-operates - this will be the perfect bounce off the support and ma.
These are days that will test your faith in a stock. What will help you is the DD you have done to justify holding this stock.
If the DD has not changed... look at it as a great buying opportunity to accumulate - if you can stomach it!
Cheers.
Adding to my portfolio and still holding...
In my opinion ... it is consolidating at these levels. The MMs are replenishing their inventory for the next push.
I have not come across any other stock that has so much REAL potential (compared to all the other junk that is out there).
Once we blast through the next 2 ceilings at .43 and .50s, we are free and clear.
This will get visibility after the PR comes out from Quest. Then we "should" be in the $1 range. Once the revenues start streaming in ... $5-$10 will come real quick.
When you add the other companies results into the mix, you will wonder what was I thinking when the stock was trading <$1 - shouldn't I have bought more at .25 or .31 or .40 (does it matter a few pennies here and there) when the stock is trading above $1 and beyond.
This is NOT a short term trade for me.
Staying long ... and accumulating on dips.
Very true 'TechStockBob'.
I have this seedling in several accounts both IRA and non-IRA.
It should be gratifying to watch this grow up into a tree!
Best to you!
This gem is my retirement stock ... heh heh
Yes, I meant to say "Insiders own 42% of the stock"
Thanks for catching that.
Recent article in NY Times about concern of screening's effectiveness from American Cancer Society - sure is kicking up a storm.
http://www.nytimes.com/2009/10/21/health/21cancer.html?scp=2&sq=cancer&st=cse
http://www.nytimes.com/2009/10/22/health/22screen.html?_r=1&scp=4&sq=cancer&st=cse
Last night, I saw more coverage on TV news - although people are aware of the screening's lack of effectiveness, you can imagine how this company's targeted tests will revolutionize the industry.
Keep in mind, 42% of the insiders own this stock - just adds to the faith the employees of this company have in their company.
This is just the beginning ... of targeted diagnostics at the gene/protein level.
There is support here at .30 short term and it "should" hold.
Let's see. Good volume of 2.4m indicates either MMs are replenishing their supplies or new buyers coming in - likely the former.
If .30 is taken out, there is a good base at .25.
Regardless, I am holding - just watching this play out the short term gyrations.
Great news.... thanks for sharing that discussion Bena had with Iain - and also for highlighting the key points!
I would concur with you - this will be too big an industry for a giant company NOT to participate in a big way. I would think either Softie or Google would be prime candidates...
Come on now... break out of this 2 cent ceiling!
HDVY needs to consolidate here - after a great run up. I am hoping it will stay in the .37-.43 area for a couple of days - before it breaks this ceiling.
Good volume at 1.6 million so far.
Next resistance at .02 - let's see how it reacts.
Ha ha ... Clawmann is our "Pacer" - Thank you Clawmann for having kept close watch!
6 month chart view of NEOM - has good volume on the way up from the lows... here's wishing a good blast off
Yes clawmann .... let's see how it rolls out over the next couple of weeks.
True... but this is a landmark settlement that paves the way for good commercialization of this nascent industry.
The stock is either being held down so MMs can accumulate (even though they had plenty of time to do so) or something else is going on.
Stock is not at all responsive. I will hold for the future potential .. but initial reaction is very anti-climactic!
Hmmm ... so far the stock is responding very sluggishly.
I would have expected the price to be at .04 AT LEAST.
Good news though... will have to wait longer for the news to seep in.
Nice climb today! Was away from PC whole day.
Will keep dreaming ...
Degreed - Excellent synopsis. Thanks for reiterating the information.
TheXpert: Quest is validating the 4 gene biomarker test and has not yet revealed their results. Once those results are out, a PR will come out and then Quest will begin marketing this test.
That is my understanding. Degreed and other experts have a better understanding as they have followed this stock for a long time.
Looks like it - Monday's action should confirm it.
Do we have any estimate when Quest might give results of their tests? I presume it is any day now...
I am estimating for a mid November PR.
Let's see how this shapes up.... until then a nice and slow climb to .75 or so and then the PR comes out to take above the key $1 level.
Dreaming....
Thanks for sharing that article - good to see that this company is still under the radar.
Steady consolidation going on ...